PMID: 8592629Jan 1, 1995Paper

Primary hyperoxaluria type 2

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
M A Mansell

Abstract

Most cases of primary hyperoxaluria are due to deficiency of hepatic peroxisomal alanine:glyoxylate aminotransferase [i.e. primary hyperoxaluria type 1 (PH1), McKusick 259900] and several hundred examples have been described since the original report in 1925. By contrast, primary hyperoxaluria type 2 (PH2, McKusick 260000) is very rare indeed with only 22 patients recorded since the original description in 1968. PH2 is characterized by hyperoxaluria and L-glyceric aciduria and is caused by deficiency of D-glycerate dehydrogenase/glyoxylate reductase. In comparison with PH1 much less is known about PH2 and considerable uncertainties remain about its frequency, clinical course and optimum management.

Citations

Feb 1, 1997·Transplantation Proceedings·M DurlikM Lao
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·G W McCaughan, A Zekry
Nov 26, 2009·Nature Reviews. Nephrology·Francesco LocatelliBenedetta Tucci
Sep 7, 2011·Nature Reviews. Nephrology·Alastair J HutchisonPaul E C Brenchley
Dec 21, 2011·Nature Reviews. Nephrology·Philip Kam-Tao Li, Kai Ming Chow
Jan 10, 2001·Pathology International·K Ohashi
Jun 2, 1998·Kidney International·B V MurthyB J Pereira
Jan 20, 1999·Kidney International·N IsmailE Ritz
Jun 3, 1999·Kidney International·P Ureña, M C De Vernejoul
Jan 14, 2000·Kidney International. Supplement·T B Drüeke
Aug 11, 2000·Kidney International. Supplement·A Santoro
Aug 11, 2000·Kidney International. Supplement·G PertosaF P Schena
Sep 29, 2001·Kidney International·M S SeverE Ark
Sep 5, 2001·Kidney International·S T MorrisA G Jardine
Jan 12, 2002·Kidney International·Silvio CavalcantiAntonio Santoro
Jan 12, 2002·Kidney International·John KyriazisIrene Grimani
Jan 12, 2002·Kidney International·Eric BoulangerPhilippe Dequiedt
Feb 19, 2002·Kidney International·Dominic S C RajRichard A Robbins
May 25, 2002·Kidney International·Paul W ChamneyVolker Wizemann
Jun 26, 2002·Kidney International·Carmine ZoccaliUNKNOWN CREED Investigators
Mar 13, 2003·Kidney International·David O McGregorM Gary Nicholls
Mar 13, 2003·Kidney International·Demetrios V VlahakosNicolaos E Madias
Feb 12, 2004·Kidney International. Supplement·Catherine M Hoff
Feb 12, 2004·Kidney International. Supplement·Anand VardhanRaymond T Krediet
Nov 24, 1999·Kidney International. Supplement·C RoncoR Bellomo
Oct 12, 2002·Immunopharmacology and Immunotoxicology·Abbas MirshafieyMasoumeh Hadjavi
Aug 8, 2002·Diabetes Technology & Therapeutics·Geoffrey BonerMark E Cooper
Feb 28, 2008·Thyroid : Official Journal of the American Thyroid Association·Georgios KaranikasMartin Willheim
Jul 31, 2008·The Annals of Occupational Hygiene·Sabine WickerHolger F Rabenau
Dec 13, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mariano FerianiUNKNOWN Study Group
Mar 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Michel JadoulUNKNOWN HCV Collaborative Group
Mar 20, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·István PintérJudit Nagy
Jan 6, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Francesco LocatelliPietro Zucchelli
Sep 8, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Karin MoretJeroen Kooman
Dec 20, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David W JohnsonJiaqi Qian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Luis Gustavo Modelli AndradeAndré Luis Balbi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
K MatousovicS Nephrologists
© 2021 Meta ULC. All rights reserved